RBV Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Romania, Bulgaria
Industries Focus
- Healthcare
- Life Sciences
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Medical Research
- Clinical Trials
- Regenerative Medicine
- Oncology
- Immunology
- Genomics
- Medical Technology
- Health IT
Investor Details Founded: 2014
RBV Capital is a dedicated life sciences venture fund based in Zug, Switzerland, established in 2014. The firm focuses on investing in diversified assets within the healthcare sector, including pharmaceuticals, biologics, digital healthcare products, and medical devices. Their investment strategy targets companies addressing unmet medical and market needs with the potential for global outreach.
The firm's approach encompasses various stages of company development, from seed to late-stage investments, including Series A, Series B, and pre-IPO rounds. RBV Capital's geographical focus spans multiple countries, including Switzerland, the United States, Germany, the United Kingdom, France, Italy, Spain, the Netherlands, Belgium, Austria, Denmark, Sweden, Norway, Finland, Ireland, Poland, the Czech Republic, Hungary, Romania, and Bulgaria. This broad reach enables the firm to identify and support innovative healthcare solutions across diverse markets.
RBV Capital's portfolio includes companies operating in sectors such as healthcare, biotechnology, pharmaceuticals, medical devices, digital health, diagnostics, life sciences, medical technology, health IT, medical research, clinical trials, regenerative medicine, genomics, immunology, and oncology. By investing in these areas, the firm aims to foster the development of groundbreaking medical technologies and treatments that can address significant health challenges worldwide.
Requirements
- Companies addressing unmet medical and market needs
- Potential for global outreach
- Innovative healthcare solutions
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$39.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of RBV Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim